Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
Next >
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
Tickers
AMGN
BLUE
CRSP
EDIT
Tags
Market News
VRTX
AMGN
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Tickers
ABNB
ALKS
AMZN
ANL
Tags
ONON
CRTO
Initiation
From
Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
Tickers
BEAM
CRSP
EDIT
GNOM
Tags
NASDAQ:EDIT,NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:VRTX,NASDAQ:SRPT,NASDAQ:NTLA,NASDAQ:BEAM
CRSP
GNOM
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
October 18, 2023
Tickers
ALB
ALPN
ARM
BIP
Tags
Initiation
WLK
BIP
From
Benzinga
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
October 18, 2023
Tickers
BEAM
EDIT
Tags
Market News
EDIT
Recent Press Releases
From
Motley Fool
Analyst Ratings for Editas Medicine
October 18, 2023
Tickers
EDIT
Tags
EDIT
Market News
Analyst Ratings
From
Benzinga
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
October 17, 2023
Tickers
BLUE
CRSP
EDIT
Tags
News
EDIT
Briefs
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Tickers
ACA
ACAD
ACDC
ACLX
Tags
EBAY
FUL
CYBR
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 17, 2023
Tickers
AHG
AMAM
ARDX
EDIT
Tags
NTCT
Market News
SPRC
From
InvestorPlace
NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
October 17, 2023
Tickers
AMAM
EDIT
ERIC
NOK
Tags
Top Losers
Movers
EDIT
From
Benzinga
Is Editas Stock a Buy Now?
October 07, 2023
Tickers
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Avoid Big Losses With Biotech Stocks by Paying Attention to These 2 Things
October 05, 2023
Tickers
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics
October 02, 2023
Tickers
CRSP
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 29, 2023
Tickers
ADD
APRN
ASTI
BCLI
Tags
Movers
OPGN
APRN
From
Benzinga
Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock
September 29, 2023
Tickers
CRSP
EDIT
Tags
Biotech
Small Cap
CRSP
From
Benzinga
Why Editas Medicine Stock Is Soaring Today
September 29, 2023
Tickers
CRSP
EDIT
SF
VRTX
Tags
EDIT
Market News
VRTX
From
Motley Fool
Expert Ratings for Editas Medicine
September 29, 2023
Tickers
EDIT
Tags
EDIT
Analyst Ratings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Tickers
ABBV
ADBE
ADSK
AKAM
Tags
EDIT
BALL
BRK
From
Benzinga
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
September 29, 2023
Tickers
ACN
DPZ
EDIT
FEMY
Tags
News
EDIT
Price Target
From
Benzinga
Nike, OPKO Health And Other Big Stocks Moving Higher In Friday's Pre-Market Session
September 29, 2023
Tickers
BMBL
BROG
EDIT
FOLD
Tags
BMBL
STEM
Top Gainers
From
Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 25, 2023
Tickers
AA
AGRI
ALEC
AVTX
Tags
CANO
ALEC
LI
From
Benzinga
1 Gene Editing Stock to Buy Now, and 1 to Sell
September 23, 2023
Tickers
CRBU
EDIT
Tags
Market News
CRBU
EDIT
From
Motley Fool
Analyst Expectations for Editas Medicine's Future
August 29, 2023
Tickers
EDIT
Tags
Benzinga
BZI/AAR
EDIT
From
Benzinga
These 2 Stocks Could Skyrocket by 54% and 119%, According to Wall Street
August 23, 2023
Tickers
EDIT
NTLA
Tags
EDIT
NTLA
Market News
From
Motley Fool
Expert Ratings for Editas Medicine
August 03, 2023
Tickers
EDIT
Tags
Benzinga
BZI/AAR
EDIT
From
Benzinga
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks
June 29, 2023
Tickers
BLUE
CRSP
EDIT
NTLA
Tags
Recent Press Releases
CRSP
EDIT
From
Motley Fool
Is Editas Medicine Stock a Buy Now?
June 28, 2023
Tickers
EDIT
Tags
Market News
EDIT
Recent Press Releases
From
Motley Fool
After It Fell 15% in 1 Day, Should You Buy The Dip on Editas Stock?
June 20, 2023
Tickers
EDIT
Tags
Recent Press Releases
Market News
EDIT
From
Motley Fool
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 15, 2023
Tickers
ALDX
AXLA
BBLG
BENF
Tags
Top Gainers
Markets
ZVSA
From
Benzinga
2 Short-Squeeze Candidates That Could Go Parabolic
June 15, 2023
Tickers
BLUE
CRSP
EDIT
NTLA
Tags
BLUE
Market News
NTLA
From
Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.